Table of Contents Table of Contents
Previous Page  2 / 3 Next Page
Information
Show Menu
Previous Page 2 / 3 Next Page
Page Background

Global Cardiology Congress 2019

Journal of Cardiovascular Medicine and Therapeutics | Volume 3

Page 15

June 19-20, 2019 | Dublin, Ireland

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

CARDIOLOGY AND

CARDIOVASCULAR MEDICINE

6

th

International Conference on

ATRIAL SEPTAL DEFECT CLOSURE

IN JEHOVAH’S WITNESS AS PART

ENHANCED RECOVERY AFTER SURGERY

PROGRAM

Background:

The great advance of anaesthesiology, surgery and crit-

ical care allow a perioperative management on the basis of enhanced

outcome. ERAS protocols are multimodal perioperative care pathways

designed to accelerate postoperative convalescence and reduce general

morbidity. So that, nearly every patient–even high risk patients such as

Jehovah Witnesses (JWs)-presenting for cardiac surgery may be consid-

ered for ERAS. However, whichever posterior readmission to the Inten-

sive Care Unit (ICU) is associated with higher mortality. Therefore, identi-

fying patients along with a well-motivatedmultidisciplinary clinical team

and optimal perioperative management will be essential for a successful

outcome. Cardiac surgery in JWs is occurring more often. Since they re-

ject heterogenic blood products, the management of anaemia remains

challenging. ERAS protocols, which include transfusion avoidance strat-

egies are desirable.

Method:

A 55-year-old female Jehovah‘s Witness (JWs) patient was

scheduled for surgical closure of an atrial septal defect (ASD), ostium se-

cundum, through an enhanced recovery after surgery (ERAS) program

respecting the patient‘s religious beliefs of rejection of blood transfu-

sions. The ERAS focuses on advances in minimally invasive heart surgery,

multimodal anaesthetic techniques and careful perioperative manage-

ment, facilitated early tracheal extubation and hospital discharge with-

out sacrificing perioperative safety.

Maria Amparo Lopez-Ruiz, J Cardiovasc Med Ther 2019, Volume 3

Maria Amparo Lopez-Ruiz has completed her

PhD from Valencia University and Postdoctoral

studies from CEU Cardinal Herrera Health Scienc-

es Faculty, Spain. She obtained her Doctorate

in Medicine with the doctoral thesis on “Anal-

ysis of the use of medication in the paediatric

population that visit accident and emergency

department” with Summa Cum Laude. She has

achieved the qualification of University Expert in

Neonatology from the Catholic University in Va-

lencia and Master’s Degree in Neonatology (from

de SENeo-Neonatology Spanish Society)”. She is

Medicine Degree Coordinator in CEU Cardinal

Herrera University since 2015. She is the Director

of the Master’s Degree in Neonatal intensive care

and Neonatal Nursing. She has attended to Inter-

national Congresses of Pediatrics as a keynote

speaker and she has been part of the Organizing

Committee member for the 12

th

International

Conference on Pediatric Pathology and Laborato-

ry Medicine, for the 11

th

International Conference

and Exhibition on Pharmacovigilance and Drug

Safety and for the 17

th

International Conference

on Pathology and Cancer Epidemiology. One of

her latest publications is “White coat syndrome:

A reality beyond the myth. A review of the liter-

ature” and as an Anatomy Professor she is an ex-

pertise in heart anatomy and cardiac dissection.

maria.lopez5@uchceu.es

Maria Amparo Lopez-Ruiz

CEU Cardinal Herrera University, Spain

BIOGRAPHY